Power of the Gut - Microbiome testing of Leucine Rich Bio

▴
The microbes present in our gastrointestinal speaks volumes about the way we feel and more about our health. It is to uncover more about this gut that three people together started Leucine Rich Bio.

Many of us go by our gut feeling and why should we not? A plethora of research suggests there is an eminent link between our brain and gut. The microbes present in our gastrointestinal speaks volumes about the way we feel and more about our health. It is to uncover more about this gut that three people together started Leucine Rich Bio in 2014.

Debojyoti Dhar had completed his post-doctoral programme from UMass Medical School and came to India to further his career. Here while working in Connexios Life Science he met his fellow co-founders, Kumar Sankaran and Prabhath Manjappa. They decided to combine their backgrounds in bioinformatics, genomics and system biology to create a new venture.

The initial plan decided by Dhar, Sankaran and Manjappa was to create a platform that helped oncologists study the mutations present in genomic data. Later the trio decided to shift their focus on giving applications of genomics reports. They wanted to uncover the potential for microbiome power in preventive healthcare. For this, they require stool samples to extract the patients’ DNA.

The collected samples would then undergo screening using algorithms and a decision matrix. Their report would then give results based on the ‘disease susceptibility index’ along with a tailor-made nutrition plan and information on necessary probiotics and prebiotics. They became South Asia’s first Microbiome Company. They created a patent-waiting gut microbiome test named BugSpeaks. They also created Rychbiome, a gut microbiome nutraceutical product. 

In 2019, Leucine Rich Bio won the award for Microbiome Diagnostic from Frost & Sullivan. The same year they also received the Super Startup Asia Award. They raised ₹2 crores in the seed round from Omphalos Ventres. Later in 2019, they raised another ₹50 lakhs from an unknown angel investor. This year they raised an unknown amount from MassChallenge Switzerland as Non-Equity Assistance. With the new funds, the venture plans to expand on its global presence and invest in a wet laboratory. 

This venture can be used in multiple healthcare domains like oncology, mental health and even reproductive health. Will Leucine Rich Bio fulfil its plan to share preventive healthcare and precision medicine worldwide?

Tags : #LeucineRichBio #DebojyotiDhar #KumarSankaran #PrabhathManjappa #gut #guthealth #FrostSullivan #OmphalosVentres #funding #startup #MakeInIndia #StartupIndia #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026